CRISPR Therapeutics AG

NASDAQ

CRSP

Stock

Yield per half year: +1.95%
Dividend yield: 0%
Sector: Healthcare

News

CRISPR Therapeutics Reports Positive Additional Phase 1 Data for CTX310™ Targeting ANGPTL3 and Provides Update on In Vivo Cardiovascular Pipeline

26 june 11:00 CRISPR Therapeutics Reports Positive Additional Phase 1 Data for CTX310™ Targeting ANGPTL3 and Provides Update on In Vivo Cardiovascular Pipeline

Cathie Wood Just Flagged The Start Of A Biotech Revolution: These 2 Stocks With 10x Potential Are Leading It - ARK Genomic Revolution ETF ( BATS:ARKG ) , ARK Innovation ETF ( BATS:ARKK )

9 june 14:02 Cathie Wood Just Flagged The Start Of A Biotech Revolution: These 2 Stocks With 10x Potential Are Leading It - ARK Genomic Revolution ETF ( BATS:ARKG ) , ARK Innovation ETF ( BATS:ARKK )

5 Monster Stocks -- Such as Coupang -- to Hold for the Next 10 Years

20 april 13:15 5 Monster Stocks -- Such as Coupang -- to Hold for the Next 10 Years